Holen Sie sich die Stockscreener-App
34.75
5.72%
1.88
Schlusskurs vom Vortag:
$32.87
Offen:
$32.6
24-Stunden-Volumen:
42.48M
Relative Volume:
2.13
Marktkapitalisierung:
$7.72B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$101.26M
KGV:
78.98
EPS:
0.44
Netto-Cashflow:
$149.62M
1W Leistung:
+4.86%
1M Leistung:
-29.48%
6M Leistung:
+113.19%
1J Leistung:
+107.71%
1-Tages-Spanne:
$31.88
$35.20
1-Wochen-Bereich:
$31.02
$35.69
52-Wochen-Spanne:
$11.20
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
34.75 | 7.72B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
166.69 | 390.86B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.65 | 144.69B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
90.30 | 73.78B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
138.67 | 45.99B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
23.31 | 44.55B | 15.46B | 1.03B | 1.34B | 0.53 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Why Hims & Hers Health Inc. (HIMS) Went Up On Friday? - MSN
Why Hims & Hers Stock Just Collapsed - AOL
Hims & Hers Health Inc (HIMS) Stock Price Down 2.98% on Mar 21 - GuruFocus.com
Hims & Hers Health: Developing A Better Understanding (NYSE:HIMS) - Seeking Alpha
Jumping Into The FDA GambleInitiating Hims & Hers With A Buy (NYSE:HIMS) - Seeking Alpha
Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There (NYSE:HIMS) - Seeking Alpha
Why Hims & Hers Health Inc. (HIMS) Went Up On Wednesday? - Insider Monkey
Hims & Hers Health's Options Frenzy: What You Need to Know - Benzinga
Why Hims & Hers Health Inc. (HIMS) Crashed On Tuesday? - MSN
US Bancorp DE Boosts Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Bank of America Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price - Defense World
Hims & Hers Health’s chief medical officer sells $798,976 in stock - Investing.com
Is Hims & Hers Health, Inc. (HIMS) One of the Most Shorted Stocks in 2025? - Insider Monkey
Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs - Yahoo Finance
Hims & Hers Health Faces Stock Decline Due to FDA ConcernsNews and Statistics - IndexBox, Inc.
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Yahoo Finance
Why Hims & Hers Stock Tumbled on Tuesday - Yahoo Finance
Why Hims & Hers Health Stock Faces Challenges - TipRanks
BofA raises Hims & Hers stock target to $22, keeps underperform - Investing.com
BofA raises Hims & Hers stock price target to $22 - Investing.com
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? - Benzinga
Hims & Hers Health’s (HIMS) App Downloads Surged in February, Says Top Analyst - Markets Insider
Raymond James Financial Inc. Purchases Shares of 746,406 Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Why Hims & Hers Stock Popped on Monday - Yahoo
Hims & Hers Health (HIMS): Among the Stocks That Outperform the Broader Market - Insider Monkey
Hims & Hers Health Inc (HIMS) Shares Up 5.07% on Mar 17 - GuruFocus.com
Why Hims & Hers Health, Inc. (HIMS) Went Up On Wednesday? - MSN
‘Don’t Buy the Dip,’ Says Morgan Stanley About Hims & Hers Stock - TipRanks
Hims & Hers health officer sells $76,598 in stock By Investing.com - Investing.com Canada
Hims & Hers health officer sells $76,598 in stock - Investing.com
Hims & Hers Stock Gains 8.6% in Three Months: How to Play It? - MSN
Why Hims & Hers Health Shares Are Falling - TipRanks
Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects - TipRanks
Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today - Yahoo Finance
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick. - The Wall Street Journal
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers - GlobeNewswire
Hims & Hers threw a Super Bowl Hail Mary that landed incomplete. Now the receiver is on the sidelines. - Sherwood News
Check Out What Whales Are Doing With HIMS - Benzinga
Cautious Outlook on Hims & Hers Health Amid Aggressive Revenue Targets and Competitive Challenges in Weight Loss Market - TipRanks
Keybank National Association OH Takes $237,000 Position in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Purchased by Smartleaf Asset Management LLC - Defense World
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hims Hers Health Inc-Aktie (HIMS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Carroll Patrick Harrison | Chief Medical Officer |
Mar 18 '25 |
Sale |
34.31 |
23,287 |
798,977 |
209,661 |
| Dudum Andrew | Chief Executive Officer |
Mar 17 '25 |
Option Exercise |
2.43 |
125,335 |
304,564 |
226,447 |
| Dudum Andrew | Chief Executive Officer |
Mar 17 '25 |
Sale |
33.98 |
128,127 |
4,353,124 |
173,655 |
| Dudum Andrew | Chief Executive Officer |
Mar 18 '25 |
Sale |
33.85 |
78,760 |
2,666,199 |
94,895 |
| Dudum Andrew | Chief Executive Officer |
Mar 17 '25 |
Sale |
33.64 |
47,534 |
1,599,170 |
380,262 |
| Boughton Soleil | Chief Legal Officer |
Mar 18 '25 |
Sale |
34.31 |
3,236 |
111,027 |
173,521 |
| Becklund Irene | PAO |
Mar 18 '25 |
Sale |
34.31 |
8,277 |
283,984 |
10,210 |
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):